afp464
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00369200)
Timeline
Indications
Mechanism of action
- Aryl hydrocarbon receptorACTIVATOR
AHR activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- afp464
- afp464
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01233947 | Phase 2 | May 1, 2011 | Baylor University, Kirax |
| NCT00348699 | Phase 1 | Jul 1, 2006 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT00369200 | Phase 1 | Jun 1, 2006 | National Cancer Institute (NCI), Wayne State University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 2 | 1 | 2006 |
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Kirax | For profit | 1 | 1 | 1 | 2011 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Wayne State University | Academic/Hospital | 1 | 0 | 1 | 2006 |
5 organizations
Page 1 / 1